[Treatment of obesity with fenfluramine (Ponderal)].
D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D004435:Eating / Q000187:drug effects; D005260:Female; D005277:Fenfluramine / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000097:blood / Q000188:drug therapy*; D010919:Placebos; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D010919:Placebos; D014280:Triglycerides; D005277:Fenfluramine; D002784:Cholesterol
Behandling af adipositas med fenfluramin (Ponderal.